Qingsong Health Forges Strategic Alliance with Basel Medical for Mutual Technological Advancement

Stock News06-10 19:08

Qingsong Health (ASX: 02661) has announced the signing of a three-year strategic cooperation memorandum with Basel Medical Group Limited (Nasdaq: BMGL).

The collaboration, established on June 10, 2026, is founded on the group's proprietary Zhengyuanfang•MedClaw medical AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI health solutions.

The primary objective of this partnership is to foster a two-way development process involving both technology export and iterative technological enhancement.

Both parties concur that integrating Qingsong Health's validated health AI infrastructure with Basel Medical's clinical settings and market access in Southeast Asia will facilitate the intelligent upgrade of regional healthcare services.

This synergy is also expected to create new market opportunities for both entities.

The initial plan involves utilizing the group's AIcare technology stack as a foundation to support Basel Medical in implementing AI-native upgrades for its medical services across Southeast Asia.

Furthermore, the companies aim to jointly expand their presence in the regional market, establishing a long-term and stable strategic partnership.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107020050?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 19:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107020050","market":"sh","top_or_hot":-1,"title":"Qingsong Health Forges Strategic Alliance with Basel Medical for Mutual Technological Advancement","media":"Stock News","content":"<p><b>Qingsong Health</b> (<b>ASX: 02661</b>) has announced the signing of a three-year strategic cooperation memorandum with Basel Medical Group Limited (<b>Nasdaq: BMGL</b>).<br><br>The collaboration, established on June 10, 2026, is founded on the group's proprietary Zhengyuanfang•MedClaw medical AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI health solutions.<br><br>The primary objective of this partnership is to foster a two-way development process involving both technology export and iterative technological enhancement.<br><br>Both parties concur that integrating Qingsong Health's validated health AI infrastructure with Basel Medical's clinical settings and market access in Southeast Asia will facilitate the intelligent upgrade of regional healthcare services.<br><br>This synergy is also expected to create new market opportunities for both entities.<br><br>The initial plan involves utilizing the group's AIcare technology stack as a foundation to support Basel Medical in implementing AI-native upgrades for its medical services across Southeast Asia.<br><br>Furthermore, the companies aim to jointly expand their presence in the regional market, establishing a long-term and stable strategic partnership.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qingsong Health Forges Strategic Alliance with Basel Medical for Mutual Technological Advancement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQingsong Health Forges Strategic Alliance with Basel Medical for Mutual Technological Advancement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-10 19:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Qingsong Health</b> (<b>ASX: 02661</b>) has announced the signing of a three-year strategic cooperation memorandum with Basel Medical Group Limited (<b>Nasdaq: BMGL</b>).<br><br>The collaboration, established on June 10, 2026, is founded on the group's proprietary Zhengyuanfang•MedClaw medical AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI health solutions.<br><br>The primary objective of this partnership is to foster a two-way development process involving both technology export and iterative technological enhancement.<br><br>Both parties concur that integrating Qingsong Health's validated health AI infrastructure with Basel Medical's clinical settings and market access in Southeast Asia will facilitate the intelligent upgrade of regional healthcare services.<br><br>This synergy is also expected to create new market opportunities for both entities.<br><br>The initial plan involves utilizing the group's AIcare technology stack as a foundation to support Basel Medical in implementing AI-native upgrades for its medical services across Southeast Asia.<br><br>Furthermore, the companies aim to jointly expand their presence in the regional market, establishing a long-term and stable strategic partnership.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159891","symbol_name":"医疗","start_time":0,"source_url":"","article_id":"1107020050","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107020050","pubTimestamp":1781089704,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Qingsong Health (ASX: 02661) has announced the signing of a three-year strategic cooperation memorandum with Basel Medical Group Limited (Nasdaq: BMGL).The collaboration, established on June 10,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","02661":"轻松健康","BK1219":"保健护理服务"},"translate_title":"青松健康与巴塞尔医疗结成战略联盟技术共进","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"02661":1},"content_text":"Qingsong Health (ASX: 02661) has announced the signing of a three-year strategic cooperation memorandum with Basel Medical Group Limited (Nasdaq: BMGL).The collaboration, established on June 10, 2026, is founded on the group's proprietary Zhengyuanfang•MedClaw medical AI collaboration system and AIcare technology stack, along with its extensive experience in implementing AI health solutions.The primary objective of this partnership is to foster a two-way development process involving both technology export and iterative technological enhancement.Both parties concur that integrating Qingsong Health's validated health AI infrastructure with Basel Medical's clinical settings and market access in Southeast Asia will facilitate the intelligent upgrade of regional healthcare services.This synergy is also expected to create new market opportunities for both entities.The initial plan involves utilizing the group's AIcare technology stack as a foundation to support Basel Medical in implementing AI-native upgrades for its medical services across Southeast Asia.Furthermore, the companies aim to jointly expand their presence in the regional market, establishing a long-term and stable strategic partnership.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107020050","isCrawlerRequest":true}